Patents by Inventor Jonathan K. FALLEN

Jonathan K. FALLEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-L1 antibodies and methods of making and using thereof
    Patent number: 11560431
    Abstract: The application provides the anti-PD-L1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: January 24, 2023
    Assignee: BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD.
    Inventors: Brian Kovacevich, Dong Xia, Anne E. Jensen, Jonathan K. Fallen, Blair Renshaw, Jeffrey B. Adamo, Phil Tan, Zeren Gao, Yi Zhu
  • Anti-PD-1 antibodies and methods of making and using thereof
    Patent number: 11466084
    Abstract: The application provides anti-PD-1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: October 11, 2022
    Assignee: SYSTIMMUNE, INC.
    Inventors: Brian Kovacevich, Dong Xia, Anne E. Jensen, Jonathan K. Fallen, Blair Renshaw, Jeffrey B. Adamo, Phil Tan, Zeren Gao, Yi Zhu
  • ANTI-PD-L1 ANTIBODIES AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20220002417
    Abstract: The application provides the anti-PD-L1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
    Type: Application
    Filed: June 22, 2018
    Publication date: January 6, 2022
    Inventors: Brian KOVACEVICH, Dong XIA, Anne E. JENSEN, Jonathan K. FALLEN, Blair RENSHAW, Jeffrey B. Adamo, Phil TAN, Zeren GAO, Yi ZHU
  • ANTI-PD-1 ANTIBODIES AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20200157219
    Abstract: The application provides anti-PD-1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 21, 2020
    Inventors: Brian KOVACEVICH, Dong XIA, Anne E. JENSEN, Jonathan K. FALLEN, Blair RENSHAW, Jeffrey B. Adamo, Phil TAN, Zeren GAO, Yi ZHU